Viatris Inc. 0A5V.IL Stock
Viatris Inc. Price Chart
Viatris Inc. 0A5V.IL Financial and Trading Overview
Viatris Inc. stock price | 11.23 USD |
Previous Close | 9.73 USD |
Open | 0 USD |
Bid | 9.39 USD x N/A |
Ask | 10.38 USD x N/A |
Day's Range | 9.85 - 9.85 USD |
52 Week Range | 8.44 - 12.3 USD |
Volume | 760 USD |
Avg. Volume | 6.92K USD |
Market Cap | 11.81B USD |
Beta (5Y Monthly) | 1.175704 |
PE Ratio (TTM) | 6.0796294 |
EPS (TTM) | 1.51 USD |
Forward Dividend & Yield | 0.48 (5.00%) |
Ex-Dividend Date | May 23, 2023 |
1y Target Est | N/A |
0A5V.IL Valuation Measures
Enterprise Value | 30.13B USD |
Trailing P/E | 6.0796294 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.7474159 |
Price/Book (mrq) | 0.56425095 |
Enterprise Value/Revenue | 1.907 |
Enterprise Value/EBITDA | 5.626 |
Trading Information
Viatris Inc. Stock Price History
Beta (5Y Monthly) | 1.175704 |
52-Week Change | -5.83% |
S&P500 52-Week Change | 20.43% |
52 Week High | 12.3 USD |
52 Week Low | 8.44 USD |
50-Day Moving Average | 9.45 USD |
200-Day Moving Average | 10.27 USD |
0A5V.IL Share Statistics
Avg. Volume (3 month) | 6.92K USD |
Avg. Daily Volume (10-Days) | 4.06K USD |
Shares Outstanding | 1.2B |
Float | 1.19B |
Short Ratio | N/A |
% Held by Insiders | 0.27% |
% Held by Institutions | 79.18% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.48 |
Trailing Annual Dividend Yield | 4.93% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0.3057 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 12.05% |
Operating Margin (ttm) | 15.86% |
Gross Margin | 43.00% |
EBITDA Margin | 33.89% |
Management Effectiveness
Return on Assets (ttm) | 3.04% |
Return on Equity (ttm) | 9.20% |
Income Statement
Revenue (ttm) | 15.8B USD |
Revenue Per Share (ttm) | 13.06 USD |
Quarterly Revenue Growth (yoy) | -11.00000000000000000000000000000000% |
Gross Profit (ttm) | 7.03B USD |
EBITDA | 5.35B USD |
Net Income Avi to Common (ttm) | 1.9B USD |
Diluted EPS (ttm) | 1.62 |
Quarterly Earnings Growth (yoy) | -43.70% |
Balance Sheet
Total Cash (mrq) | 587.6M USD |
Total Cash Per Share (mrq) | 0.49 USD |
Total Debt (mrq) | 19.03B USD |
Total Debt/Equity (mrq) | 90.94 USD |
Current Ratio (mrq) | 1.577 |
Book Value Per Share (mrq) | 17.455 |
Cash Flow Statement
Operating Cash Flow (ttm) | 2.79B USD |
Levered Free Cash Flow (ttm) | 4.6B USD |
Profile of Viatris Inc.
Country | United Kingdom |
State | PA |
City | Canonsburg |
Address | 1000 Mylan Boulevard |
ZIP | 15317 |
Phone | 724 514 1800 |
Website | https://www.viatris.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 38000 |
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides its medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as glargine and SEMGLEE names. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; Momenta Pharmaceuticals, Inc.; Theravance Biopharma, Inc.; and Fujifilm Kyowa Kirin Biologics Co. Ltd. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.
Q&A For Viatris Inc. Stock
What is a current 0A5V.IL stock price?
Viatris Inc. 0A5V.IL stock price today per share is 11.23 USD.
How to purchase Viatris Inc. stock?
You can buy 0A5V.IL shares on the IOB exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Viatris Inc.?
The stock symbol or ticker of Viatris Inc. is 0A5V.IL.
Which industry does the Viatris Inc. company belong to?
The Viatris Inc. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Viatris Inc. have in circulation?
The max supply of Viatris Inc. shares is 1.21B.
What is Viatris Inc. Price to Earnings Ratio (PE Ratio)?
Viatris Inc. PE Ratio is 7.43708560 now.
What was Viatris Inc. earnings per share over the trailing 12 months (TTM)?
Viatris Inc. EPS is 1.51 USD over the trailing 12 months.
Which sector does the Viatris Inc. company belong to?
The Viatris Inc. sector is Healthcare.